{"id":942220,"date":"2026-03-05T09:33:41","date_gmt":"2026-03-05T14:33:41","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/repligen-corporation-to-present-at-upcoming-march-conferences\/"},"modified":"2026-03-05T09:33:41","modified_gmt":"2026-03-05T14:33:41","slug":"repligen-corporation-to-present-at-upcoming-march-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/repligen-corporation-to-present-at-upcoming-march-conferences\/","title":{"rendered":"Repligen Corporation to Present at Upcoming March Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>WALTHAM, Mass., March  05, 2026  (GLOBE NEWSWIRE) &#8212; Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be participating in three upcoming investor conferences.<\/p>\n<ul type=\"disc\">\n<li style=\"margin-top:4pt\">The Leerink Global Healthcare Conference, being held March 8 \u2013 11 in Miami. Jason Garland, Chief Financial Officer, will participate in an analyst led discussion at 11:20 a.m. ET on Tuesday, March 10, 2026.<\/li>\n<li style=\"margin-top:4pt\">The Barclays 28th Annual Global Healthcare Conference, being held March 10 \u2013 12 in Miami. Jason Garland, Chief Financial Officer, will participate in an analyst led discussion at 10:30 a.m. ET on Wednesday, March 11, 2026.<\/li>\n<li style=\"margin-top:4pt\">The 2026 KeyBanc Virtual Healthcare Forum, being held March 17 \u2013 18. Olivier Loeillot, President and Chief Executive Officer, will participate in an analyst led discussion at 2:15 p.m. ET on Wednesday, March 18, 2026.<\/li>\n<\/ul>\n<p>A live webcast of the Leerink and KeyBanc presentations will be accessible through Repligen\u2019s <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YrF0LYuX--hvd7Ywp8Q4ALZkYBKFfr5k66-CeUE1jRPWMwBqgmxqMBu3TuWIUzy_jC-XYU1P7U5W2H1_yojHMkR5nHZrVs8Et3Bnh9wBaH5T1hvVt0V5NtwuMzC1nCQLBufNlRk3hkQYhg3tHVhmPg==\" rel=\"nofollow\" target=\"_blank\">Investor Relations<\/a> website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9zYiRRQpgM6uAF2BBAYq7cMI4Nz-WJ0dLUikqKj_uhCckabJ-DSKnvc-zVqwUm0RD6NmqBKwe2GLcW3zSqTq76KZiVn4SXt8PefYOIiZAkE=\" rel=\"nofollow\" target=\"_blank\">www.repligen.com<\/a>, and will be available for replay for a limited period of time following the events.<\/p>\n<p align=\"justify\">\n        <strong>About Repligen Corporation<\/strong><br \/>\n        <br \/>Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. We are <em>\u201cinspiring advances in bioprocessing\u201d<\/em> for the customers we serve; primarily biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Our focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Our corporate headquarters are located in Waltham, Massachusetts, and the majority of our manufacturing sites are in the U.S., with additional key sites in Estonia, France, Germany, Ireland, the Netherlands and Sweden. For more information about the company see our website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9zYiRRQpgM6uAF2BBAYq7TYr_HtVfhGT5TK-cB_oHJb305eMfCoMnSlExR1km6zdPRLl4_DQjzDHH2kjsxrvhk9pe1F9MWQ2XmYvBqZUvS4=\" rel=\"nofollow\" target=\"_blank\">www.repligen.com<\/a>, and follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4BgmEEn5eIiBpHLpu1HV8DoToUCOpSzrTPYH1JiEHDNifPuFiH6etXWC4tviLqhFZxSrzlN-zTDJYv6T_ZsK_YgEtZMzXzXfwF40G7BHuAvRwjE0bO3XiniqFcxeoGCK\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>\n        <strong>Repligen Contact: <\/strong><br \/>\n        <br \/>Jacob Johnson<br \/>VP, Investor Relations<br \/>781-419-0204<br \/>investors@repligen.com<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NjA5NSM3NDY4MzU5IzIwMDUyMzg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/OWNmZGZlNWUtMTdhMS00MTViLWJkMDItMDU2ZjBhMWM2Yjc2LTEwMTY4MTEtMjAyNi0wMy0wNS1lbg==\/tiny\/Repligen-Corporation.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WALTHAM, Mass., March 05, 2026 (GLOBE NEWSWIRE) &#8212; Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be participating in three upcoming investor conferences. The Leerink Global Healthcare Conference, being held March 8 \u2013 11 in Miami. Jason Garland, Chief Financial Officer, will participate in an analyst led discussion at 11:20 a.m. ET on Tuesday, March 10, 2026. The Barclays 28th Annual Global Healthcare Conference, being held March 10 \u2013 12 in Miami. Jason Garland, Chief Financial Officer, will participate in an analyst led discussion at 10:30 a.m. ET on Wednesday, March 11, 2026. The 2026 KeyBanc Virtual Healthcare Forum, being held March 17 \u2013 18. Olivier Loeillot, President and Chief Executive &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/repligen-corporation-to-present-at-upcoming-march-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Repligen Corporation to Present at Upcoming March Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-942220","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Repligen Corporation to Present at Upcoming March Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/repligen-corporation-to-present-at-upcoming-march-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Repligen Corporation to Present at Upcoming March Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WALTHAM, Mass., March 05, 2026 (GLOBE NEWSWIRE) &#8212; Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be participating in three upcoming investor conferences. The Leerink Global Healthcare Conference, being held March 8 \u2013 11 in Miami. Jason Garland, Chief Financial Officer, will participate in an analyst led discussion at 11:20 a.m. ET on Tuesday, March 10, 2026. The Barclays 28th Annual Global Healthcare Conference, being held March 10 \u2013 12 in Miami. Jason Garland, Chief Financial Officer, will participate in an analyst led discussion at 10:30 a.m. ET on Wednesday, March 11, 2026. The 2026 KeyBanc Virtual Healthcare Forum, being held March 17 \u2013 18. Olivier Loeillot, President and Chief Executive &hellip; Continue reading &quot;Repligen Corporation to Present at Upcoming March Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/repligen-corporation-to-present-at-upcoming-march-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-05T14:33:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NjA5NSM3NDY4MzU5IzIwMDUyMzg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/repligen-corporation-to-present-at-upcoming-march-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/repligen-corporation-to-present-at-upcoming-march-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Repligen Corporation to Present at Upcoming March Conferences\",\"datePublished\":\"2026-03-05T14:33:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/repligen-corporation-to-present-at-upcoming-march-conferences\\\/\"},\"wordCount\":294,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/repligen-corporation-to-present-at-upcoming-march-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2NjA5NSM3NDY4MzU5IzIwMDUyMzg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/repligen-corporation-to-present-at-upcoming-march-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/repligen-corporation-to-present-at-upcoming-march-conferences\\\/\",\"name\":\"Repligen Corporation to Present at Upcoming March Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/repligen-corporation-to-present-at-upcoming-march-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/repligen-corporation-to-present-at-upcoming-march-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2NjA5NSM3NDY4MzU5IzIwMDUyMzg=\",\"datePublished\":\"2026-03-05T14:33:41+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/repligen-corporation-to-present-at-upcoming-march-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/repligen-corporation-to-present-at-upcoming-march-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/repligen-corporation-to-present-at-upcoming-march-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2NjA5NSM3NDY4MzU5IzIwMDUyMzg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2NjA5NSM3NDY4MzU5IzIwMDUyMzg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/repligen-corporation-to-present-at-upcoming-march-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Repligen Corporation to Present at Upcoming March Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Repligen Corporation to Present at Upcoming March Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/repligen-corporation-to-present-at-upcoming-march-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Repligen Corporation to Present at Upcoming March Conferences - Market Newsdesk","og_description":"WALTHAM, Mass., March 05, 2026 (GLOBE NEWSWIRE) &#8212; Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be participating in three upcoming investor conferences. The Leerink Global Healthcare Conference, being held March 8 \u2013 11 in Miami. Jason Garland, Chief Financial Officer, will participate in an analyst led discussion at 11:20 a.m. ET on Tuesday, March 10, 2026. The Barclays 28th Annual Global Healthcare Conference, being held March 10 \u2013 12 in Miami. Jason Garland, Chief Financial Officer, will participate in an analyst led discussion at 10:30 a.m. ET on Wednesday, March 11, 2026. The 2026 KeyBanc Virtual Healthcare Forum, being held March 17 \u2013 18. Olivier Loeillot, President and Chief Executive &hellip; Continue reading \"Repligen Corporation to Present at Upcoming March Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/repligen-corporation-to-present-at-upcoming-march-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2026-03-05T14:33:41+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NjA5NSM3NDY4MzU5IzIwMDUyMzg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/repligen-corporation-to-present-at-upcoming-march-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/repligen-corporation-to-present-at-upcoming-march-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Repligen Corporation to Present at Upcoming March Conferences","datePublished":"2026-03-05T14:33:41+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/repligen-corporation-to-present-at-upcoming-march-conferences\/"},"wordCount":294,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/repligen-corporation-to-present-at-upcoming-march-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NjA5NSM3NDY4MzU5IzIwMDUyMzg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/repligen-corporation-to-present-at-upcoming-march-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/repligen-corporation-to-present-at-upcoming-march-conferences\/","name":"Repligen Corporation to Present at Upcoming March Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/repligen-corporation-to-present-at-upcoming-march-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/repligen-corporation-to-present-at-upcoming-march-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NjA5NSM3NDY4MzU5IzIwMDUyMzg=","datePublished":"2026-03-05T14:33:41+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/repligen-corporation-to-present-at-upcoming-march-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/repligen-corporation-to-present-at-upcoming-march-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/repligen-corporation-to-present-at-upcoming-march-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NjA5NSM3NDY4MzU5IzIwMDUyMzg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2NjA5NSM3NDY4MzU5IzIwMDUyMzg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/repligen-corporation-to-present-at-upcoming-march-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Repligen Corporation to Present at Upcoming March Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/942220","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=942220"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/942220\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=942220"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=942220"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=942220"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}